NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life ...
Conduit Pharmaceuticals Inc. announced a 1-for-15 reverse stock split of its common stock, approved by its board and stockholders, effective May 19, 2025. Following this split, every fifteen shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback